- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03989141
Creating a Buttonhole Tunnel Track by Repeated Needling of the AV Fistula on the Same Day in Patients on Hemodialysis.
BACKGROUND: The patients diagnosed with end stage renal disease require dialysis and for that they need to have a vascular access for hemodialysis (HD) placed. Vascular access complications are the most common cause of hospitalization among patients in HD. An AV fistula (AVF) is a surgical connection made between an artery and a vein, created by a vascular specialist, typically placed in an arm. AV fistulas are the preferred vascular access for long-term dialysis. In order to be able to carry out an adequate and uncomplicated dialysis treatment, two needles have to be placed in the fistula. It requires specialized technical ability to install well-functioning needles in the vessels of an AVF. The buttonhole technique is one of the two recommended techniques. For the buttonhole technique, two puncture sites are selected in the fistula. Here, exactly in the same spot a needle is inserted with the same angle and direction until a fibrous tunnel is formed, like a hole for an ear ring. Cannulation is now possible with blunt needles which are gentler and reduce complications. The time required to create a buttonhole tunnel is 6-12 cannulations, ie 6-12 dialyses. It is crucial for the future survival of the tunnel tracks, that a maximum of one to two persons cannulates until the track is created. This is a logistic challenge in a busy dialysis unit and may result in using a cannulation technique that is not recommended. A less time consuming method to create the buttonhole tunnel track may increase the use of the technique. A new method has been used in several dialysis units in Denmark. Using this method the tunnel tracks are created in 1-3 dialyses by repeated cannulations (4-6 needles one at a time) in the same two puncture sites in the fistula. The experiences so far indicates that this method reduces the dialysis sessions needed to create the tunnel tracks with 4-10 sessions. Thus, the logistic challenges of ensuring continuity in persons creating the tunnel track will be reduced. The purpose of the research project is to investigate whether a new method for creating buttonhole tunnels will:
- Increase the number of well-functioning buttonholes.
- Be less painful for the patient.
- Reduce the number of dialysis needed to create the buttonhole tunnel track.
- Cause unchanged or fewer fistula associated complications and infections.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: See above. Aims:To study whether a new method of creating a buttonhole tunnel tracks can reduce the incidence of buttonhole technique failure and the patients pain with needling.
Patients and Methods: A randomized, multi-center study enrolling 42 patients in hemodialysis from two HD units in Denmark. The study will begin end of May 2019.
Participants are randomized into 2 groups where cannulation will be carried out by a small group of dialysis nurses with experience and skills in buttonhole cannulation. In both groups the same nurse will carry out the cannulation the first four dialysis sessions. At the following sessions the cannulation will be carried out by the nurse/nurses responsible for the patient. The procedures throughout the study will be the same in both participating centers.
The control group (K): creating buttonhole tunnels according to the standard method, ie. cannulation with a single sharp cannula in the AVF at each dialysis for 6-12 dialyses until a blunt needle can be inserted.
The intervention group (I): creating buttonhole tunnels according to the new method, ie. repeated cannulation with several sharp needles (4-6 pieces) at each dialysis for 1-3 dialyses until a blunt cannula can be inserted.
The creation of a buttonhole tunnel track is defined as completed when two consecutive dialyses have been carried out with no use of sharp needles, however no longer than 24 dialysis sessions.Thus, the period of time will be of different length for each participant. In the period until the tunnel is created, data will be collected at each dialyses regarding number of cannulations, type of needle (sharp or blunt), cannulator and patient-experienced pain with needling.
The primary outcome is buttonhole technique failure defined as the need for cannulations carried out using sharp needles in the buttonhole for three consecutive dialyses or in case lack of ability to insert blunt needles in the buttonhole for 2 weeks.
Follow-up from the date of the completed creation of the buttonhole tunnel track in both groups:
12 month ongoing follow-up of the primary outcome buttonhole survival and the secondary outcomes AVF associated infections, complications and AVF survival.
Sample size:The power calculation is based on the expected incidence of the primary outcome measure: buttonhole technique failure. Based on calculations in the two dialysis centers from randomly selected patients with buttonhole tunnels made using the intervention and the control method, it appears that the estimated buttonhole technique failure is 10 % and 30 %, respectively.
Drop-off rate is estimated to 30%. The number of participants for the study is calculated at 21 subjects in each group to achieve a power of 0.8 with a type error rate of 0.5.
Intention-to-treat analysis will be carried out. Censoring in case of death, if the person wants to withdraw from the study or moves, AV fistula failure for non-buttonhole associated causes and kidney transplant.
Statistical analysis:The baseline characteristics of the study population will be presented as counts and proportions and compared between randomization groups with chi-square test / Fisher's exact test (depending on number of observations) for categorical variables. Continous variables will be presented as mean (SD), respectively, median (IQR) depending on normality of data and compared between groups by t-test, respectively, Wilcoxon rank-sum test. Normality will be evaluated by quantile plots and Shapiro-Wilks test. Moreover, repeated measurements will be compared by mixed effects models. Time to event outcomes will be compared by the Kaplan-Meier method and tested by log-rank test, furthermore discrete time survival methods will be applied as a sensitivity analysis. P-values <0.05 are regarded as statistically significant. Follow-up will be censored at 1 year. Statistical analysis will be performed using Stata, version 11.0 (StataCorp, College Station, Tex., USA).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Esbjerg, Denmark, 6700
- Hospital South West Jutland, Esbjerg
-
Kolding, Denmark, 6000
- Kolding Sygehus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- chronic hemodialysis patients
- at least 5 hemodialysis treatments with a blood flow ≥ 250 ml/min have been carried out
- ability to speak and understand danish
Exclusion Criteria:
- patients with an artificial heart valve
- patients in high dose immunosuppressive treatment
- patients with infections in their buttonholes
- patients who are unable to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Repeated cannulation Buttonhole
The intervention group (I): repeated needling into the same site in the AVF with sharp needles (4-6 pieces) at each dialysis (1-3 dialyses) creating a buttonhole tunnel track where cannulation with a blunt needle is possible.
|
The intervention group (I): repeated needling into the same site in the AVF with sharp needles (4-6 pieces) at each dialysis (1-3 dialyses) creating a buttonhole tunnel track where cannulation with a blunt needle is possible.
Other Names:
|
|
Active Comparator: Single cannulation Buttonhole
The control group (C): needling into the same site in the AVF with 1 sharp needle at each dialysis (6-12 dialyses) creating a buttonhole tunnel track, where cannulation with a blunt needle is possible. .
|
The control group (C): needling into the same site in the AVF with 1 sharp needle at each dialysis (6-12 dialyses) creating a buttonhole tunnel track, where cannulation with a blunt needle is possible. .
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Buttonhole survival
Time Frame: Follow up for 1 year after completed creation of buttonhole tunnel
|
Cannulation with a blunt needle in the buttonhole tunnel track is possible.
Technique failure and non-survival is defined as inability to insert a blunt needle into the buttonhole tunnel tracks in three consecutive dialysis or inability to cannulate the established buttonhole track for more than two weeks.
|
Follow up for 1 year after completed creation of buttonhole tunnel
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient perceived pain post-needling
Time Frame: Measured at each cannulation until completed creation of buttonhole tunnel track (up to 24 dialyses=8 weeks)
|
Measuring the patients pain at buttonhole needling using a validated numeric rating scale (NRS) for pain with 0 representing one pain extreme (e.g., "no pain") and 10 representing the other pain extreme (e.g., "pain as bad as you can imagine" and "worst pain imaginable"
|
Measured at each cannulation until completed creation of buttonhole tunnel track (up to 24 dialyses=8 weeks)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of dialyses required to create a buttonhole tunnel track
Time Frame: up to 24 dialyses=8 weeks
|
A buttonhole tunnel track is considered created when 2 consecutive dialyses have been carried out using blunt needles with no use of sharp needles.
Failure in creation: when the tunnel can't be needled with a blunt needle after 24 dialyses
|
up to 24 dialyses=8 weeks
|
|
AV fistula associated event
Time Frame: Follow up for 1 year after completed creation of buttonhole tunnel
|
buttonhole infections, AV fistula infections, AV fistula failure, surgical fistula interventions (thrombosis, aneurysm, stenosis, steal syndrome).
|
Follow up for 1 year after completed creation of buttonhole tunnel
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Mette KM Axelsen, RN,MHS, Hospital SWJ
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Pathologic Processes
- Male Urogenital Diseases
- Pathological Conditions, Anatomical
- Kidney Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Chronic Disease
- Disease Attributes
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Kidney Failure, Chronic
- Fistula
Other Study ID Numbers
- Buttonhole project
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End-stage Renal Disease (ESRD)
-
Rockwell Medical Technologies, Inc.CompletedEnd-Stage Renal Disease (ESRD)United States, Canada
-
National Taiwan University HospitalUnknown
-
University of Kansas Medical CenterCompletedEnd-stage Renal Disease (ESRD) | Chronic Kidney Disease (CKD)United States
-
Outset MedicalCompletedAcute Kidney Injury | End Stage Renal Disease (ESRD) | End Stage Renal Disease on DialysisUnited States
-
FibroGenAstraZenecaCompletedAnemia Associated With End Stage Renal Disease (ESRD)United States
-
Ionis Pharmaceuticals, Inc.BayerCompletedEnd-stage Renal Disease (ESRD)Canada
-
Ionis Pharmaceuticals, Inc.BayerCompletedEnd-stage Renal Disease (ESRD)Spain
-
Ottawa Hospital Research InstituteHeart and Stroke Foundation of OntarioCompletedEnd-stage Renal Disease (ESRD) | Kidney DiseaseCanada
-
Bristol-Myers SquibbCompletedThrombosis | Renal Impairment | Factor XI | ESRD (End-Stage Renal Disease)United States
-
Icahn School of Medicine at Mount SinaiCompletedEnd Stage Renal Disease (ESRD)United States
Clinical Trials on Repeated cannulation Buttonhole.
-
Cliniques universitaires Saint-Luc- Université...CompletedChronic Hemodialysis Patients | Vascular Abord: Native Arterio-venous Fistula | Buttonhole CannulationBelgium
-
Ottawa Hospital Research InstituteBaxter Healthcare CorporationCompleted
-
Ajou University School of MedicineCompleted
-
Jessa HospitalWithdrawn
-
Azienda Usl di BolognaNiguarda Hospital; Catania Hospital GastroenterologyCompletedBiliary Tract DiseasesItaly
-
Marmara UniversityCompletedRadial Artery Cannulation | Arterial CatheterizationTurkey
-
Medical University of GdanskCompleted
-
Dongliang Zhang, MDTerminatedArteriovenous FistulaChina
-
St. Jude Children's Research HospitalCompletedCannulationUnited States
-
Diskapi Teaching and Research HospitalNot yet recruitingCardiac Surgery | Radial Artery Cannulation | Cardiac Surgery in Adult Patient | Arterial Cannulation | Radial Artery CatheterizationTurkey (Türkiye)